Navigation Links
Cowen Group, Inc. Announces 2008 First Quarter Results
Date:5/8/2008

erest 43 141

Other 5,122 6,197

Total expenses 52,725 70,917

Operating income 2,265 2,624

Gain on exchange memberships - 1,775

Income before income taxes 2,265 4,399

Provision for income taxes 1,611 1,928

Net income $654 $2,471

Earnings per share:

Basic $0.06 $ 0.19

Diluted $0.05 $ 0.18

Weighted average shares used in per share data:

Basic 11,253 12,910

Diluted 11,895 13,417

Other Metrics at March 31, 2008 and 2007

Stockholders' equity $203,451 $225,128

Common shares outstanding 14,429 15,900

Book value per share $14.10 $14.16

Tangible book value per share* $10.63 $11.01

* Tangible book value per share is calculated as follows: Shareholders'

equity, less $50 million of goodwill, divided by common shares

outstanding.

Cowen Group, Inc.

Non-GAAP Financial Measures

Q1:08 Q1:07

(dollars in millions)

Reconciliation of Operating

Income to Adjusted Net Operating

(Loss) Income

Operating income $2.3 $2.6

Exclusion of compensation

(rever
'/>"/>

SOURCE Cowen Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ISTA Pharmaceuticals Engages Cowen as Financial Advisor
2. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
3. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
4. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
5. MannKind to Present at the Cowen and Company Healthcare Conference
6. Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
7. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
8. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
9. XTENT to Present at Cowen and Companys 28th Annual Health Care Conference
10. Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17
11. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)...ndorsements,Business,andPressJoinEfforttoEducate ...-Onceagain,theNationalBipolarFoundationandtheMedic...Safe,tilStable"program,whichisnowbeingwidelyaccept....Today,theNationalBipolarFoundationreceivedaprocla...omtheLt.GovernorofLouisianaMitchLandrieu.TheNation...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
(Date:11/25/2009)...lood pressure? This simple question has been the ...ess-related gene Modulates High Blood Pressure in ... This simple question has been the focus of intens...or the first time established a link between a nov...e to stress in mice as well as humans. The studies...
(Date:11/25/2009)...to fight rheumatoid arthritis, could help newly di...SDAY, Nov. 25 (HealthDay News) -- A drug commonly ...d arthritis now also shows some promise in helping..., The drug, rituximab (Rituxan), helped patients ...ugh the disease had destroyed some of their pancre...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
.... 31 Biopure Corporation,(Nasdaq: BPUR ) announc...ommon stock will revert from BPURD to BPUR at the ... Outstanding warrants that trade on the OTCBB,will...re Corporation develops, manufactures and markets ...
.../PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TS...company focused on,endocrine therapy and oncology,...d operating results before market open on Wednesda...ants may,access the live webcast via the Company,s...
...ct. 31 Allos,Therapeutics, Inc. (Nasdaq: ALTH ),...pment and commercialization of small molecule ther...ced that Paul L. Berns, President and,CEO, will pr... (Eastern) on,Tuesday, November 6, 2007. There wil...
... a record $175 million; net book-to-bill of 1.7:1,...an all-time Company high, - Third quarter operat... - Third quarter EPS of $0.25 (GAAP) and $0.48...endle (Nasdaq: KNDL ), a,leading, global full-ser...
...DVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a biop...used on commercializing proprietary product candid...seases, announced today that Evan M. Levine,ADVENT...The conference takes place in New York at the Wald...
...t. 30 Medical Services,International Inc. (OTC Pi...as added 4 additional distributors in the month of...utorships these corporations will have to purchase...,a Dengue Fever Kit and only one other manufacture...
Other Medicine News:Health News:Biopure's Stock Symbol Reverts to BPUR 2Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 3Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 4Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 5Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 6Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 7Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 8Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 9Health News:ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference 2
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Che...aldatafromtheCompany,sPROTECT-1(theProspectiveRand...fTraficet-EN(TM)(CCX282-B)inpatientswithmoderate-t...withafavorablesafetyandtolerabilityprofile.Thestud...ionofdiseaseseverityasdefinedasa70-pointdecreasein...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:Ro...arsfollowinganautoaccident,wasactuallyfullyconscio...ningAmericasegment.TheDynaVoxEyeMaxwasfeaturedinth...andotherconditionscanunlockcommunication. ,, WH...leonlineat www.dynavoxtech.com ,, WHO:Ro...
(Date:11/24/2009)..., MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--Qu...eadingproviderofdiagnostictesting,informationandse...nnualPiperJaffrayHealthcareConferenceinNewYorkCity...2009at9:30a.m.EasternTime. ,, Duringtheconferen...growthtoapproximate3%,operatingincometoexceed18%of...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 1LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 2Novavax Announces Appointment of John J Trizzino as Senior Vice President International and Government Alliances 13127 1Novavax Announces Appointment of John J Trizzino as Senior Vice President International and Government Alliances 13127 2Biomarkers May Predict Alzheimers 52316 1Biomarkers May Predict Alzheimers 52316 2Biomarkers May Predict Alzheimers 52316 3
... Influenza Conference, HIGH WYCOMBE, England, June...re-clinical data showing how a new flu vaccine has...nfluenza, including,pandemic and annual, was prese...e Control of Influenza VI (Options) Conference, in...h will be published in the,European Journal of Imm...
...007-Active Biotech (OMX Nordic: ACTI),has presente...th,World Congress on Inflammation (<a target="_bla...flammation2007.dk ) held,in Copenhagen June 16-20*...evelopment of,57-57 for the treatment of SLE and s... Phase II clinical trials are planned to be,initia...
Other Medicine Technology:New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4Active Biotech presents new pre-clinical data for the 57-57 project,at the 8th World Congress on Inflammation 2
...lly invasive treatment option for female patients ...The Monarc treats SUI by supporting the urethra du...ughing or laughing. Monarc's outside-to-in transob...c's transobturator approach and knitted, polypropy...
Uretex® Self-Anchoring Urethral Support System
Bard Dermal Allograft
NephroMax High Pressure Nephrostomy Balloon Catheters
Medicine Products: